Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 8
2004 11
2005 8
2006 6
2007 14
2008 19
2009 26
2010 20
2011 22
2012 34
2013 21
2014 34
2015 36
2016 35
2017 30
2018 42
2019 46
2020 17
Text availability
Article attribute
Article type
Publication date

Search Results

383 results
Results by year
Filters applied: . Clear all
Page 1
Extracellular Matrix Scaffolds for Tissue Engineering and Regenerative Medicine.
Yi S, Ding F, Gong L, Gu X. Yi S, et al. Among authors: ding f. Curr Stem Cell Res Ther. 2017;12(3):233-246. doi: 10.2174/1574888X11666160905092513. Curr Stem Cell Res Ther. 2017. PMID: 27593448 Review.
The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation.
He J, Gao HX, Yang N, Zhu XD, Sun RB, Xie Y, Zeng CH, Zhang JW, Wang JK, Ding F, Aa JY, Wang GJ. He J, et al. Among authors: ding f. Acta Pharmacol Sin. 2019 Jan;40(1):86-97. doi: 10.1038/s41401-018-0043-5. Epub 2018 Jun 21. Acta Pharmacol Sin. 2019. PMID: 29930278 Free PMC article.
Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma.
Zhang C, Li J, Huang T, Duan S, Dai D, Jiang D, Sui X, Li D, Chen Y, Ding F, Huang C, Chen G, Wang K. Zhang C, et al. Among authors: ding f. Oncotarget. 2016 Dec 6;7(49):81255-81267. doi: 10.18632/oncotarget.13221. Oncotarget. 2016. PMID: 27835605 Free PMC article. Review.
APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma.
Faden DL, Ding F, Lin Y, Zhai S, Kuo F, Chan TA, Morris LG, Ferris RL. Faden DL, et al. Among authors: ding f. Oral Oncol. 2019 Sep;96:140-147. doi: 10.1016/j.oraloncology.2019.07.020. Epub 2019 Jul 30. Oral Oncol. 2019. PMID: 31422205
Targeted high-throughput sequencing technique for the molecular diagnosis of primary immunodeficiency disorders.
Chi ZH, Wei W, Bu DF, Li HH, Ding F, Zhu P. Chi ZH, et al. Among authors: ding f. Medicine (Baltimore). 2018 Oct;97(40):e12695. doi: 10.1097/MD.0000000000012695. Medicine (Baltimore). 2018. PMID: 30290665 Free PMC article. Clinical Trial.
Biomedical Applications of Glycoconjugates.
Ding F, Zhang Y. Ding F, et al. Mini Rev Med Chem. 2018;18(18):1508-1523. doi: 10.2174/1389557518666180518083427. Mini Rev Med Chem. 2018. PMID: 29773059 Review.
NEAT1/miR-23a-3p/KLF3: a novel regulatory axis in melanoma cancer progression.
Ding F, Lai J, Gao Y, Wang G, Shang J, Zhang D, Zheng S. Ding F, et al. Cancer Cell Int. 2019 Aug 22;19:217. doi: 10.1186/s12935-019-0927-6. eCollection 2019. Cancer Cell Int. 2019. PMID: 31462890 Free PMC article.
Melanoma-Induced Reprogramming of Schwann Cell Signaling Aids Tumor Growth.
Shurin GV, Kruglov O, Ding F, Lin Y, Hao X, Keskinov AA, You Z, Lokshin AE, LaFramboise WA, Falo LD Jr, Shurin MR, Bunimovich YL. Shurin GV, et al. Among authors: ding f. Cancer Res. 2019 May 15;79(10):2736-2747. doi: 10.1158/0008-5472.CAN-18-3872. Epub 2019 Mar 26. Cancer Res. 2019. PMID: 30914431 Free PMC article.
Neural tissue engineering options for peripheral nerve regeneration.
Gu X, Ding F, Williams DF. Gu X, et al. Among authors: ding f. Biomaterials. 2014 Aug;35(24):6143-56. doi: 10.1016/j.biomaterials.2014.04.064. Epub 2014 May 10. Biomaterials. 2014. PMID: 24818883 Review.
Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson's Disease Models.
Zhang Y, Guo H, Guo X, Ge D, Shi Y, Lu X, Lu J, Chen J, Ding F, Zhang Q. Zhang Y, et al. Among authors: ding f. Int J Environ Res Public Health. 2019 Oct 10;16(20):3811. doi: 10.3390/ijerph16203811. Int J Environ Res Public Health. 2019. PMID: 31658620 Free PMC article.
383 results
Jump to page